L. Zhang

机构：Jiangyin People's Hospital, Jiangyin Traffic Planning Survey & Design Institute (China) · ORCID：0000-0001-6308-5038

发表论文 25 篇 · 总被引 104 次 · h-index 7

代表论文

• DNA Tetrahedron Delivering miR‐21‐5p Promotes Senescent Bone Defects Repair through Synergistic Regulation of Osteogenesis and Angiogenesis (2024 · Advanced Healthcare Materials · 被引 23)
• Yes‐associated protein promotes cell migration via activating Wiskott‐Aldrich syndrome protein family member 1 in oral squamous cell carcinoma (2019 · Journal of Oral Pathology and Medicine · 被引 14)
• Evaluation of clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) recruited in China in a phase III, randomized, open-label, first-line study in Asia of gefitinib (G) versus carboplatin/paclitaxel (C/P) (IPASS) (2009 · Journal of Clinical Oncology · 被引 14)
• Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy (2025 · Frontiers in Immunology · 被引 11)
• First-passage problem of strongly nonlinear stochastic oscillators with external and internal resonances (2012 · European Journal of Mechanics - A/Solids · 被引 9)
• 2094O SKYSCRAPER-07: A phase III, randomised study of atezolizumab (atezo) with or without tiragolumab (tira) in patients (pts) with unresectable esophageal squamous cell carcinoma (ESCC) that has not progressed following definitive concurrent chemoradiotherapy (dCRT) (2025 · Annals of Oncology · 被引 8)